title: Use of fondaparinux (ARIXTRA) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II.
authors.affiliation: Department of Nephrology, University and Teaching Hospitals, Humboldt Univeristy of Berlin, Germany. michael.haase@charite.de
authors.forename: Michael
authors.initials: M
authors.lastname: Haase
authors.forename: Rinaldo
authors.initials: R
authors.lastname: Bellomo
authors.forename: Jens
authors.initials: J
authors.lastname: Rocktaeschel
authors.forename: Sabine
authors.initials: S
authors.lastname: Ziemer
authors.forename: Holger
authors.initials: H
authors.lastname: Kiesewetter
authors.forename: Stanislao
authors.initials: S
authors.lastname: Morgera
authors.forename: Hans-H
authors.initials: HH
authors.lastname: Neumayer
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D000077425:Fondaparinux; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011134:Polysaccharides / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000188:drug therapy* / Q000209:etiology*; D013927:Thrombosis / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D011134:Polysaccharides; D006493:Heparin; D000077425:Fondaparinux